SUMMARY
Volatile anaesthetic agents form the mainstay of general anaesthesia and may be suitable particularly for older patients. They have a good safety record for patients of all ages, are easy to administer and provide a convenient means of varying anaesthetic depth. Unfortunately, in common with i.v. agents, volatile anaesthetics depress the cardiovascular system.
The cardiovascular side effects of both halothane and isoflurane have been well studied in young, healthy volunteers, but there is little information on their effects in an older patient population. Isoflurane has some theoretical advantages for use in older patients because of its low blood solubility [1] , the limited extent of its biodegradation [2] and minimal cardiovascular depressant effect [3] [4] [5] . Previous work in our department with volatile agents has shown that uptake of halothane, but not of isoflurane, decreased in older adults [6] .
In this study we have compared the cardiovascular effects of isoflurane and halothane when given in equipotent doeses to young and elderly adult patients.
PATIENTS AND METHODS
After obtaining University Research Ethics Committee approval and their informed consent, we studied 40 patients aged 60 yr or more and 40 patients aged 20-40 yr, all within 20 % of their predicted lean body mass and ASA I or II. Patients were excluded if they were receiving any cardioactive medication, had recently received halothane or had a history of malignant hyperthermia. Temazepam 10-20 mg was given by mouth 1 h before the study commenced.
Patients were allocated randomly, on a stratified basis for age, to four equal groups of 20 to receive either isoflurane or halothane at the minimum alveolar concentration (1 MAC) in 100 % oxygen for the young and old age ranges (1.15% or 1.05% isoflurane; 0.75 % or 0.65 % halothane) according to previous findings [7, 8] . Anaesthesia was induced with etomidate 0.3 mg kg" 1 , followed by 1-mg increments for initial maintenance. Atracurium 0.5 mg kg" 1 was given at the same time to facilitate tracheal intubation with a Portex gas sampling tube, 90 s after induction.
Two minutes after intubation (time 0), the volatile agent was introduced in an inspired concentration designed to achieve 1 MAC (end-tidal) within 2 min. Patients' lungs were ventilated to end-tidal carbon dioxide partial pressures of 4.5 kPa (elderly) or 4.8 kPa (young) in order to compensate for agerelated differences in the relationship between PE C O, and Pac Oi [6] . Measurements of arterial pressure, heart rate, cardiac output and volatile agent were made at time 0 and every 2 min for 20 min. During this time, the patient remained undisturbed and the inspired volatile agent concentration was adjusted to maintain 1 MAC expired concentration measured by a Datex Normac.
Cardiac output was measured using a Datascope Accucom cardiac output monitor, which uses the Doppler principle to measure blood velocity in the ascending aorta; aortic blood flow is derived by time integration of the velocity profile and this is multiplied by the cross-sectional area of the aorta [9] which is obtained from a nomogram. The measure- 16(5.4) ments in this study were taken in duplicate from the suprasternal notch. Baseline measurements of cardiac output, systemic arterial pressure and heart rate were made after a 10-min period of stabilization in the anaesthetic room. Systemic arterial pressure and heart rate were measured by a Datascope Accutorr.
Data were collected on-line, using a BBC microcomputer which was interfaced with the Accucom and the Normac [10] . The computer collected arterial pressure, heart rate and cardiac output information along with other Doppler information from the Accucom and intermittently sampled the volatile agent concentration over a 10-s period from the Normac. The computer calculated peak and trough concentrations of the volatile agent. The Normac-computer system was calibrated with a standard gas before each study. All the data were stored on disk for later retrieval. Cardiac index was calculated for each measurement using a nomogramderived estimate for body surface area.
Results were analysed using two-or three-factor repeated measures analysis of variance with Dunnett t tests for appropriate individual comparisons. Chisquare and Mann-Whitney U tests were applied to non-parametric data. Results were considered significant at the 95 % level.
Validation study
We undertook a volunteer study using the Datascope Accucom under steady state conditions, with the same investigator, over a 30-min period to assess the reliability of the machine for use as a measuring device. As expected, there was inter-individual variation in cardiac output, but little change in a given individual with time. A coefficient of reliability of 0.993 was obtained for repeated within-patient measurements. This reliability for trending is in agreement with results from other workers [11, 12] and the Doppler technique is now regarded as a reliable method for evaluating acute drug effects [13] or physiological changes [14] .
RESULTS
Patient data for the four groups are shown in tables I and II. There were no differences in drug doses administered or mean ventilatory volume and mean peak airway inflation pressure. Pa^ at the end of the study was slightly less in the elderly.
Using ANOVA there were statistically significant changes with time in all variables in each group (P < 0.05) and between the younger and older age groups (P < 0.05). Both age groups receiving halothane developed significant reductions in heart rate over the 20-min study period (tables III, IV) compared with the effects of isoflurane (tables V, VI). Halothane produced a significant decrease in cardiac index from baseline in both age groups over the duration of the study (P < 0.05), but only older patients receiving isoflurane showed a similar decrease, contrasting with unchanged values in the young.
The hypotensive effects of isoflurane were more marked in the older patients as demonstrated by disappearance, after 8 min, of the initial significant differences attributable to age. In contrast, agerelated differences in diastolic pressure persisted throughout the study period when halothane was used. During isoflurane anaesthesia and after tracheal intubation, younger patients developed a mild tachycardia, in contrast with a more stable heart rate in the elderly group. There were no age-related differences in heart rate during halothane anaesthesia. Cardiac index remained stable in the young during isoflurane anaesthesia, but there was a persistent decline in the older group. In contrast, cardiac index decreased significantly in both age groups during halothane anaesthesia. During admin- 4) istration of each volatile agent, the elderly did not increase cardiac output in response to tracheal intubation.
DISCUSSION
Until recently, it has been assumed commonly that results from studies in young, healthy volunteers could be applied without modification to patients in older age groups. However, there is now abundant evidence that the latter respond differently to many drugs [15, 16] and they are known to have a reduced MAC for volatile agents [7, 8, 17] .
Our application of the Doppler technique in young adults has produced results similar to those found by other workers for both isoflurane [3] and halothane [18] , further validating its use in these circumstances.
It has been reported that cardiac output declines by approximately 1 % yr" 1 over 30 yr [16, 19] ; heart rate also decreases and systolic arterial pressure increases with ageing. The response to hypotension and exercise is less marked [17, 19] . The baroreflex response to a Valsalva manoeuvre is known to be depressed in the elderly, with a greater change in intrathoracic pressure required to produce the same change in heart rate [19, 20] . Both myocardium and vascular smooth muscle of aged animals exhibit reduced responsiveness to catecholamine stimulation [21] [22] [23] .
Volatile agents, particularly halothane, depress baroreflex function [24] [25] [26] and exert a direct depressant effect on myocardial activity by reducing both the amount of calcium release from the sarcoplasmic reticulum and the influx of calcium to activate myofibrils [27] [28] [29] [30] . Furthermore, Lynch [31] has demonstrated a difference in the alteration in tension development induced by these two anaesthetic agents and it is suggested that the two agents produce myocardial depression by different mechanisms [32] .
Halothane depresses cardiac function in man without a change in peripheral resistance [18, [33] [34] [35] , but isoflurane apparently maintains cardiac output, perhaps with an increase in sympathetic autonomic activity [4, 5] . Contractility is depressed more by the volatile agents in a failing heart [36] and this may have some bearing on the greater depression of cardiovascular indices in older patients.
Eger and co-workers have shown, in young volunteers, that halothane is a potent myocardial depressant [18] and these findings are now confirmed in an older age group. We propose that, in elderly patients, isoflurane has a cardiac depressant effect similar to that of halothane. This contrasts with previously published work in younger adults indicating that isoflurane preserved cardiac function [3] .
The older patients exhibited a relative bradycardia with isoflurane (although less than with halothane) and this probably contributed to the decrease in cardiac output seen in this group. The baroreflex system discussed earlier may contribute to this, as isoflurane was responsible also for a greater reduction in arterial pressure.
This study has shown that elderly patients exhibit generalized cardiovascular depression with both halothane and isoflurane. This finding is not unexpected for halothane, but is at variance with previous findings in healthy younger adults with isoflurane. The reduction in diastolic arterial pressure with isoflurane may affect coronary perfusion pressure to a greater extent than occurs with halothane, suggesting that halothane is preferable in the older patient in respect of its cardiovascular effects.
